Systematic Review of Endocan as a Potential Biomarker of COVID-19

被引:18
作者
Khalaji, Amirmohammad [1 ,2 ]
Amirkhani, Nikan [1 ]
Sharifkashani, Sourena [1 ]
Peiman, Soheil [3 ]
Behnoush, Amir Hossein [1 ,2 ,4 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] AdventHlth Orlando Hosp, Dept Internal Med, Orlando, FL USA
[4] Univ Tehran Med Sci, Sch Med, Poursina St,Keshavarz Blvd, Tehran 1417613151, Iran
关键词
endocan; COVID-19; endothelial cell-specific molecule-1; ESM-1; systematic review; CARDIOVASCULAR EVENTS; HYPERTENSION; SULFATE; DISEASE;
D O I
10.1177/00033197231152941
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Since the start of the coronavirus disease 2019 (COVID-19) pandemic, several biomarkers have been proposed to assess the diagnosis and prognosis of this disease. The present systematic review evaluated endocan (a marker of endothelial cell damage) as a potential diagnostic and prognostic biomarker for COVID-19. PubMed, Scopus, Web of Science, and Embase were searched for studies comparing circulating endocan levels between COVID-19 cases and controls, and/or different severities/complications of COVID-19. Eight studies (686 individuals) were included, from which four reported significantly higher levels of endocan in COVID-19 cases compared with healthy controls. More severe disease was also associated with higher endocan levels in some of the studies. Studies reported higher endocan levels in patients who died from COVID-19, were admitted to an intensive care unit, and had COVID-19-related complications. Endocan also acted as a diagnostic and prognostic biomarker with different cut-offs. In conclusion, endocan could be a novel diagnostic and prognostic biomarker for COVID-19. Further studies with larger sample sizes are warranted to evaluate this role of endocan.
引用
收藏
页码:107 / 115
页数:9
相关论文
共 46 条
[1]   Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 [J].
Ackermann, Maximilian ;
Verleden, Stijn E. ;
Kuehnel, Mark ;
Haverich, Axel ;
Welte, Tobias ;
Laenger, Florian ;
Vanstapel, Arno ;
Werlein, Christopher ;
Stark, Helge ;
Tzankov, Alexandar ;
Li, William W. ;
Li, Vincent W. ;
Mentzer, Steven J. ;
Jonigk, Danny .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (02) :120-128
[2]   Endocan: A New Molecule Playing a Role in the Development of Hypertension and Chronic Kidney Disease? [J].
Afsar, Baris ;
Takir, Mumtaz ;
Kostek, Osman ;
Covic, Adrian ;
Kanbay, Mehmet .
JOURNAL OF CLINICAL HYPERTENSION, 2014, 16 (12) :914-916
[3]   Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes: A Preliminary Study [J].
Arman, Yucel ;
Akpinar, Timur Selcuk ;
Kose, Murat ;
Emet, Samim ;
Yuruyen, Gulden ;
Akarsu, Murat ;
Ozcan, Mustafa ;
Yegit, Ozan ;
Cakmak, Ramazan ;
Altun, Ozgur ;
Aydin, Sengul ;
Alibeyoglu, Alpay ;
Ugurlu, Bilal ;
Akcan, Tugce ;
Tukek, Tufan .
ANGIOLOGY, 2016, 67 (03) :239-244
[4]   Endocan: A novel inflammatory indicator in cardiovascular disease? [J].
Balta, Sevket ;
Mikhailidis, Dimitri P. ;
Demirkol, Sait ;
Ozturk, Cengiz ;
Celik, Turgay ;
Iyisoy, Atila .
ATHEROSCLEROSIS, 2015, 243 (01) :339-343
[5]   Endocan: A Key Player of Cardiovascular Disease [J].
Chen, Jinzhi ;
Jiang, Liping ;
Yu, Xiao-Hua ;
Hu, Mi ;
Zhang, Yang-Kai ;
Liu, Xin ;
He, Pingping ;
Ouyang, Xinping .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
[6]   Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients [J].
Chenevier-Gobeaux, Camille ;
Ducastel, Morgane ;
Meritet, Jean-Francois ;
Ballaa, Yassine ;
Chapuis, Nicolas ;
Pene, Frederic ;
Carlier, Nicolas ;
Roche, Nicolas ;
Szwebel, Tali-Anne ;
Terrier, Benjamin ;
Borderie, Didier .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
[7]   Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx [J].
du Preez, Heidi N. ;
Aldous, Colleen ;
Hayden, Melvin R. ;
Kruger, Hendrik G. ;
Lin, Johnson .
FASEB JOURNAL, 2022, 36 (01)
[8]   Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets [J].
Fodor, Adriana ;
Tiperciuc, Brandusa ;
Login, Cezar ;
Orasan, Olga H. ;
Lazar, Andrada L. ;
Buchman, Cristina ;
Hanghicel, Patricia ;
Sitar-Taut, Adela ;
Suharoschi, Ramona ;
Vulturar, Romana ;
Cozma, Angela .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
[9]   Derivation and Validation of a Predictive Score for Respiratory Failure Worsening Leading to Secondary Intubation in COVID-19: The CERES Score [J].
Gaudet, Alexandre ;
Ghozlan, Benoit ;
Dupont, Annabelle ;
Parmentier-Decrucq, Erika ;
Rosa, Mickael ;
Jeanpierre, Emmanuelle ;
Bayon, Constance ;
Tsicopoulos, Anne ;
Duburcq, Thibault ;
Susen, Sophie ;
Poissy, Julien .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
[10]   Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19 [J].
Gorgun, Selim ;
Cindoruk, Sener ;
Ozgen, Emre ;
Yadigaroglu, Metin ;
Demir, Mehmet Tevfik ;
Yucel, Murat ;
Akpinar, Cetin Kursad ;
Guzel, Murat .
ANGIOLOGY, 2021, 72 (10) :942-946